Subscribe To

Price Alert Latest News Economic Calendar News

HCM / HUTCHMED (China) Limited (HCM) CEO Christian Hogg on Q2 2022 Results - Earnings Call Transcript

HUTCHMED (China) Limited (NASDAQ:HCM ) Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants Christian Hogg - Chief Executive Officer Hong Chen - Senior Vice President and Chief Commercial Officer, China Weiguo Su - Executive Director and Chief Scientific Officer Marek Kania - Executive Vice President, Managing Director and Chief Medical Officer, International Mark Lee - Senior Vice President, Corporate Finance & Development Johnny Cheng - Executive Director and Chief Financial Officer Karen Atkin - Executive Vice President and Chief Operating Officer Simon To - Chairman, Executive Director, Hutchison China Meditech Ltd. Conference Call Participants Kelly Shi - Jeffries Paul Choi - Goldman Sachs Mike Mitchell - Panmure Gordon Yang Huang - Credit Suisse Matthew Yan - CLSA Operator Dr. Marek Kania, our Managing Director and Chief Medical Officer of HUTCHMED International. Read More

Demo Live Account See Partner Details

Content Topics

Hutchmed

China

Limited

HCM

Christian

Hogg

2022

Results

china

Earnings

Transcript

Stock

Posted: Aug 1 2022, 16:35

Author Name: Seeking Alpha

HCM News

By Zacks Investment Research
October 3, 2023

Wall Street Analysts See a 107.24% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

The mean of analysts' price targets for HUTCHMED (HCM) points to a 107.2% upside in the stock. While this highly sought-after metric has not proven re

By InvestorPlace
September 20, 2023

Beware! 3 Machine Learning Stocks Waving Massive Red Flags Right Now

Though artificial intelligence and machine learning have gotten their fair share of hype this year, not all of these companies are positioned to outpe

By Seeking Alpha
August 11, 2023

Hutchmed: Attractive Chinese R&D Giant

Hutchmed (China) Limited, a Chinese biopharma company, has experienced fluctuations in its stock price but has potential for improvement. The company

By GlobeNewsWire
June 26, 2023

HUTCHMED to Announce 2023 Half-Year Financial Results

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 26, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SE

By Zacks Investment Research
April 26, 2023

Wall Street Analysts See a 103.84% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

The consensus price target hints at a 103.8% upside potential for HUTCHMED (HCM). While empirical research shows that this sought-after metric is hard

By Zacks Investment Research
April 10, 2023

Wall Street Analysts Think HUTCHMED (HCM) Could Surge 102.73%: Read This Before Placing a Bet

The consensus price target hints at a 102.7% upside potential for HUTCHMED (HCM). While empirical research shows that this sought-after metric is hard

By Zacks Investment Research
February 10, 2023

Wall Street Analysts Believe HUTCHMED (HCM) Could Rally 61.85%: Here's is How to Trade

The mean of analysts' price targets for HUTCHMED (HCM) points to a 61.9% upside in the stock. While this highly sought-after metric has not proven rea

By GlobeNewsWire
January 31, 2023

HUTCHMED to Announce 2022 Final Results

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Jan. 31, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SE

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.